Back to search

Aristotle University Of Thessaloniki (AUTH)

Ο ρόλος της καθεψίνης Κ και των βιοχημικών δεικτών οστικού μεταβολισμού σε οστεοπορωτικές μετεμμηνοπαυσιακές γυναίκες

Abstract

dc:description

AIM: DEXA (Dual Energy X-ray Absorptiometry) has prevailed worldwide as a gold standard method in osteoporosis diagnosis. However DEXA can not predict the future bone loss or to visualize early response to antiosteoporotic treatment. Assessment of newer sensitive markers of bone metabolism in conjunction with DEXA scanning provides more information on the diagnosis and evaluation of osteoporotic women. The purpose of this study was to evaluate the changes of the carboxy terminal telopeptide of bone collagen type I (CTX), the amino terminal propeptide of procollagen type I bone (PINP) and a lysosomal cysteine protease Cathepsin K, as markers of bone metabolism in postmenopausal women, osteoporotic and non-osteoporotic, compared with premenopausal women. METHOD: 99 postmenopausal women of mean age 57+8 years and 20 healthy premenopausal women of mean age 31+5 years which were used as controls were enrolled in our study. 30 of postmenopausal women were healthy by DEXA whereas 46 were osteopenic and 23 osteoporotic. 19 out of the 69 osteopenic and osteoporotic subjects had been under antiresorptive treatment. Bone turnover markers were measured in all the above groups of patients and evaluation of their diagnostic value was undertaken in relation to the bone loss degree with the years into menopause and antiresorptive treatment or not. Circulating serum levels of CTX and PINP were determined by a specific electrochemiluminescence method in Roche Elexcys automatic analyzer whereas serum cathepsin K levels were determined by a specific sandwich enzyme immunoassay method (Biomedica, Austria). One-way ANOVA procedure with post-hoc Tukey control was used in statistical analysis. ROC curves were used for the the diagnostic accuracy evaluation of the bone turnover markers. The approximation of the optimal decision point was made by the Youden index. RESULTS: Both CTX and PINP levels in postmenopausal women were found significantly elevated compared to healthy controls (CTX: postmenopausal: 0,366 +0,102 ng / ml, controls: 0,273 +0,112 ng / ml, p = 0,002 and PINP: postmenopausal: 37,74 +9,78 ng / ml, controls: 30,13 +8,68 ng / ml, p = 0,011 respectively) whereas cathepsin K was not (postmenopausal: 4,93 +4,37 pmol / l, controls: 3,46 +1,40 pmol / l, p = 0,282). None of the three indices showed significant correlation to the degree of bone loss as it was measured by DEXA in postmenopausal women (cath k: pathological: 5,21 +4,37 pmol / l, healthy: 4.75 +2.54 pmol / l, p = 0,899, CTX: pathological: 0,382 +0,089 ng / ml, healthy: 0,354 +0,098 ng / ml, p = 0,560, PINP: pathological: 37,58 +10,47 ng / ml, healthy: 36,77 +10,52 ng / ml p = 0,904). No significant correlation was emerged of any index to the years in menopause (cath k: p = 0,832, CTX: p = 0,152, PINP: p = 0,200) or by taking antiosteoporotic treatment (cath k: p = 0,702, CTX: p = 0,832, PINP: p = 0,665). Evaluation of the diagnostic value of three markers of bone metabolism with the ROC curves emerged that CTX separates statistically significantly healthy from osteopenic of the first five years group from menopause (optimum decision point 0,36 ng / ml) and that has important diagnostic value in osteopenia for women who have> 10 years in menopause (optimum decision point 0,2 ng / ml). In contrast in the group of 5-10 years from menopause cathepsin K and PINP have statistically significant predictive value (optimal points 5,5 pmol / l and 49 ng / ml respectively).CONCLUSIONS: Our study resulted in the following conclusions: 1. CTX levels increase with time occurring in postmenopausal elevated compared to healthy premenopausal and separate healthy postmenopausal from osteopenic of the first five years group from menopause. 2. PINP levels increase with time occurring in postmenopausal elevated compared to healthy premenopausal and separate healthy postmenopausal from osteopenic and osteopenic from osteoporotic of the second five years group from menopause. 3. Cathepsin K levels was not significantly different in postmenopausal compared to premenopausal healthy but separate healthy postmenopausal from osteopenic and osteopenic from osteoporotic of the second five years group from menopause. 4. Measurement of CTX levels is useful in evaluation of postmenopausal women in the first five years of menopause whereas assessment of PINP and Cathepsin K are useful in evaluation of postmenopausal women in the second five years group from menopause. 5. Assessment of these markers in conjunction with DEXA scanning provides more data about the efficacy of the applied antiresorptive treatment in postmenopausal osteoporotic women. 6. Optimal points are different in each age group and this requires classification of normal values in correlation with years from menopause.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spanogiannis, Dimitrios
  • Σπανογιάννης, Δημήτριος

Subjects

dc:subject × 15

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38795

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spanogiannis, Dimitrios; Σπανογιάννης, Δημήτριος. Ο ρόλος της καθεψίνης Κ και των βιοχημικών δεικτών οστικού μεταβολισμού σε οστεοπορωτικές μετεμμηνοπαυσιακές γυναίκες. Aristotle University Of Thessaloniki (AUTH), 2013. http://hdl.handle.net/10442/hedi/38795